Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

human augmentation

- PMLiVE

Combining hard technology with human skills

Chris Ross explores why pharma’s multichannel maturity isn’t just about hard technology – success depends on ‘human’ enablers

- PMLiVE

Want to know if you’re dehydrated? There’s an app for that.

Water water everywhere..but are we drinking it?

Page & Page and Partners

- PMLiVE

Hancock trumpets £250m fund for AI in the health service

Ties in with NHS long-term plan

- PMLiVE

Bayer taps Sensyne Health AI and real world data for cardiovascular research

Sensyne a ‘docking station’ for anonymised NHS patient data analysis

- PMLiVE

Recursion raises $121m for AI-led drug discovery

Funds will fuel in house pipeline and tech

- PMLiVE

A postcard from Cannes

This week sees the annual Cannes Lions International Festival of Creativity, bringing together leading creative talent from across the globe to learn, share and inspire each other. Until recently, pharmaceuticals...

Bedrock Healthcare Communications

- PMLiVE

Sanofi taps Google’s expertise for digital transformation

Pharma giant embraces AI with new partnership

- PMLiVE

Myovant’s fibroids drug clears phase 3 trial, but shares sink

Investors concerned on how it stacks up against AbbVie rival

- PMLiVE

Data regulations impeding AI use in drug research

Lack of data specialists another concern

Apex and Lumentium bring a new experience to the UK event market

Specialist pharma conference and event management company Apex has signed an exclusive deal to become the sole representative of Lumentium in the UK.

Apex.co.uk Events and Exhibition Stands

Artificial Intelligence: a new character in the storytelling of drug development and discovery?

Written by Edward Jones, Junior Medical Writer. Bedrock is dedicated to creating valuable and powerful stories to engage audiences that drive an improvement in the provision of health. This focus...

Bedrock Healthcare Communications

- PMLiVE

Celgene and Exscientia sign AI drug discovery deal in oncology and autoimmunity

Firm says it cuts discovery timelines by 75%

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links